Crystal structures of the Apo and Holo form of rat catechol-O-methyltransferase

Journal of Structural Biology

Volumn 165, Issue 3, 2009, Pages 133-139

  Tsuji, Eiichi ^a,b   Okazaki, Kosuke ^a   Isaji, Masayuki ^a   Takeda, Kei ^b  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Apo form; Catechol O methyltransferase; Holo form; X ray crystal structure

Indexed keywords

APOENZYME; CATECHOL METHYLTRANSFERASE; HOLOENZYME; LIGAND; S ADENOSYLMETHIONINE;

ARTICLE; BINDING SITE; CATALYSIS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; ENZYME STRUCTURE; PRIORITY JOURNAL;

ANIMALS; APOENZYMES; BINDING SITES; CATALYTIC DOMAIN; CATECHOL O-METHYLTRANSFERASE; CATECHOLS; CRYSTALLOGRAPHY, X-RAY; HOLOENZYMES; HYDROGEN BONDING; HYDROPHOBICITY; MAGNESIUM; MODELS, MOLECULAR; PROTEIN CONFORMATION; RATS; RECOMBINANT PROTEINS; S-ADENOSYLMETHIONINE;

RATTUS;

EID: 58849155679     PISSN: 10478477     EISSN: 10958657     Source Type: Journal    
DOI: 10.1016/j.jsb.2008.11.012     Document Type: Article

References (31)

1. Bonifacio M.J., Archer M., Rodrigues M.L., Matias P.M., Learmonth D.A., Carrondo M.A., and Soares-Da-Silva P. Kinetics and crystal structure of catechol-O-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application. Mol. Pharmacol. 62 (2002) 795-805
2. Bunker A., Mannisto P.T., St. Pierre J.-F., Rog T., Pomorski P., Stimson L., and Karttunen M. Molecular dynamics simulations of the enzyme catechol-O-methyltransferase: methodological issues. SAR QSAR Environ. Res. 19 (2008) 179-189
3. CCP4: Collaborative Computational Project Number 4, 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D50, 760-763.
4. Edmond Y.L., and Thomas C.B. Importance of correlated motions in forming highly reactive near attack conformations in catechol O-methyltransferase. J. Am. Chem. Soc. 120 (1998) 12387-12394
5. Edmond Y.L., and Thomas C.B. Comparison of the dynamics for ground-state and transition-state structures in the active site of catechol-O-methyltransferase. J. Am. Chem. Soc. 122 (2000) 7165-7171
6. Guldberg H.C., and Marsden C.A. Catechol-O-methyltransferase: Pharmacological aspects and physiological role. Pharmacol. Rev. 27 (1975) 135-206
7. Kaakkola S., Gordin A., Jarvinen M., Wikberg T., Schultz E., Nissinen E., Pentikäinen P.J., and Rita H. Effect of a novel catechol-O-methyltransferase inhibitor, nitecapone, on the metabolism of l-dopa in healthy volunteers. Clin. Neuropharmacol. 13 (1990) 436-447
8. Karhunen T., Tilgmann C., Ulmanen I., Julkunen I., and Panula P. Distribution of catechol-O-methyltransferase enzyme in rat tissues. J. Histochem. Cytochem. 42 (1994) 1079-1090
9. Lautala P., Ulmanen I., and Taskinen J. Molecular mechanism controlling the rate and specificity of catechol O-methyltransferase by human soluble catechol O-methyltransferase. Mol. Pharmacol. 59 (2001) 393-402
10. Learmonth D.A., Palma P.N., Vieira-Coelho M.A., and Soares-Da-Silva P. Synthesis, biological evaluation, and molecular modeling studies of a novel, peripherally selective inhibitor of catechol-O-methyltransferase. J. Med. Chem. 47 (2004) 6207-6217
11. Lerner C., Ruf A., Gramlich V., Masjost B., Zürcher G., Joakob-Roetne R., Borroni E., and Diederich F. X-ray crystal structure of a bisubstrate inhibitor bound to the enzyme catechol-O-methyltransferase: a dramatic effect of inhibitor preorganization on binding affinity. Angew. Chem. Int. Ed. 113 (2001) 4164-4166
12. Leslie, A.G.W., 1992. Recent changes to the MOSFLM package for processing film and image plate data. In: Joint CCP4 and ESF-EAMCB Newsletter on Protein Crystallography, vol. 26. Daresbury Laboratory, Warrington, United Kingdom.
13. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melén K., Julkunen I., and Taskinen J. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34 (1995) 4202-4210
14. Lundstrom K., Tilgman C., Peranen J., Kalkkinen K., and Ulmanen I. Expression of enzymatically active rat live and human placental catechol-O-methyltransferase in Escherichia coli; purification and partial characterization of the enzyme. Biochim. Biophys. Acta 1129 (1992) 149-154
15. Männistö P.T., and Kaakkola S. New selective COMT inhibitors: useful adjuncts for Parkinson's disease?. Trends Pharmacol. Sci. 10 (1989) 54-56
16. Männistö P.T., and Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 51 (1999) 593-628
17. Masjost B., Ballmer P., Borroni E., Zurcher G., Winkler F.K., Jakob-Roente R., and Diederich F. Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT). Chem. Eur. J. 6 (2000) 971-982
18. McPherson A. Current approaches to macromolecular crystallization. Eur. J. Biochem. 189 (1990) 1-23
19. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50 (1994) 157-163
20. Paetzel M., and Dalbey R.E. Catalytic hydroxyl/amine dyads within serine proteases. Trends Biochem. Sci. 22 (1997) 28-31
21. Palma P.N., Rodrigues M.A., Bonifacio A.I., Loureiro A.I., Learmonth D.A., Carrondo M.A., and Soares-Da-Silva P. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation. Mol. Phamacol. 70 (2006) 143-153
22. Paulini R., Trindler C., Lerner C., Brandli L., Schweizer W.B., Jakob-Roente R., Zurcher G., Borroni E., and Diedrich F. Bisubstrate inhibitors of catechol O-methyltransferase (COMT): the crucial role of the ribose structural unit for inhibitor binding affinity. Chem. Med. Chem. 1 (2006) 340-357
23. Schluckebier G., O'Gara M., Saenger W., and Cheng X. Universal catalytic domain structure of AdoMet-dependent methyltransferases. J. Mol. Biol. 247 (1995) 16-20
24. Tilgman C., and Ulmanen I. Purification methods of mammalian catechol-O-methyltransferases. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 684 (1996) 147-161
25. Toney M.D., and Kirsch J.F. Direct Broensted analysis of the restoration of activity to a mutant enzyme by exogenous amines. Science 243 (1989) 1485-1488
26. Vidgren J., and Ovaska M. Structural aspects in the inhibitor design of catechol-O-methyltransferase. In: Pandi V. (Ed). Structure-based Drug Design (1997), Marcel Dekker Inc. 343-363
27. Vidgren J., Svenson L.A., and Lijias A. Crystal structure of catechol-O-methyltransferase. Nature 368 (1994) 354-358
28. Vidgren J., Ovaska M., Tenhunen J., Tilgman C., and Lotta T. Structure and evolution of AdoMet-dependent methyltransferases. In: Cheng X., and Blumenthal R.M. (Eds). S-Adenosylmethionine-Dependent Methyltransferases: Structures and Functions (1999), World Scientific, River Edge, NJ 1-38
29. Woodard R.W., Tsai M.-D., Floss H.G., Crooks P.A., and Coward J.K. Stereochemical course of the transmethylation catalyzed by catechol-O-methyltransferase. J. Biol. Chem. 255 (1980) 9124-9127
30. Zheng Y.J., and Bruice T.C. A theoretical examination of the factors controlling the catalytic efficiency of a transmethylation enzyme: catechol-O-methyltransferase. J. Am. Chem. Soc. (1997) 8137-8145
31. Zücher G., and Da Prada M. Rapid and sensitive single-step radiochemical assay for catechol-O-methyltransferase. J. Neurochem. 38 (1982) 191-195